Fractional CCO, Genomics & AI

Fractional Chief Commercial OfficerWe are supporting an innovative European TechBio company seeking an experienced fractional CCO to lead its commercial strategy and accelerate partnerships with pharmaceutical and biotechnology companies. The company combines single-cell data and AI to support biomarker discovery and drug development, with a particular focus on inflammatory diseases. The opportunity:Develop and execute the commercial and go-to-market strategySecure strategic partnerships with pharma and biotech companiesBuild and manage a strong commercial pipelineRefine the company’s positioning, proposition and partnership modelWork closely with the CEO, Board and scientific leadership team The ideal candidate:Commercial leadership experience within TechBio, biomarker discovery, single-cell technologies or precision medicineAn established network across pharmaceutical R&D and translational medicineA proven track record of securing complex pharma partnershipsComfortable operating within an early-stage, entrepreneurial businessBased in the US or Europe, with flexibility to travel This is a fractional position requiring approximately 60% commitment, with the opportunity to play a central role in the company’s next stage of commercial growth.